GENE ONLINE|News &
Opinion
Blog

2020-05-07| Interviews

Dr. Joseph Kvedar: The Potential of Telemedicine in the Era of Digitalization

by Rajaneesh K. Gopinath
Share To
Telemedicine is an intervention that facilitates patient access to healthcare outside of the doctor's office. To manage overwhelming patient populations, in recent years, hospital systems around the world have started to embrace it. The arrival of the COVID-19 pandemic has only accentuated the value of this approach with mandatory measures like lockdown and social distancing in place. "The interest in remote or virtual care delivery has been accelerating in the last five years, but our time to shine is now," says Dr. Joseph Kvedar, who has been a staunch advocate of digital health for close to three decades. A seasoned dermatologist at Harvard Medical School, Dr. Kvedar has been at the forefront of telemedicine with his eminent leadership at Partners HealthCare. We invited him for a discussion on the promise of the field.

It's free! Log in now to read

LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top